Table-5.

Antimicrobial Resistance patterns of carbapenemase-producing isolates of Enterobacteriaceae among hospitalized patients at Debre Tabor Comprehensives specialized Hospital, Northwest Ethiopia.

Isolates (n = 52)	P	Antimicrobial disks tested against the carbapenemase-producing isolates of Enterobacteriaceae (n = 52)
		CTR n (%)	CTX n (%)	CAZ n (%)	FOX n (%)	AMX n (%)	AMP n (%)	CIP n (%)	CHL n (%)	AZT n (%)	GM n (%)	TET n (%)	SXT n (%)	CPM n (%)	MEM n (%)
E. coli (n = 31)	S	10 (32.3)	4 (12.9)	0	21 (76.7)	8 (25.8)	3 (9.7)	0	0	16 (51.6)	0	0	0	3 (9.7)	23 (74.2)
	R	21 (76.7)	27 (87.1)	31 (100)	10 (32.3)	23 (74.2)	28 (90.3)	31 (100)	31 (100)	15 (48.4)	31 (100)	31 (100)	31 (100)	28 (90.3)	8 (25.8)
K. pneumoniae (n = 16)	S	7 (43.8)	10 (62.5)	0	12 (75)	2 (12.5)	2 (12.5)	1 (6.3)	0	14 (87.5)	0	0	1 (6.3)	15 (93.8)	10 (62.5)
	R	9 (56.2)	6 (37.5)	16 (100)	4 (25)	14 (87.5)	14 (87.5)	15 (93.8)	16 (100)	2 (12.5)	16 (100)	16 (100)	15 (93.8)	1 (6.3)	6 (37.5)
C. freundii (n = 2)	S	2 (100)	2 (100)	2 (100)	2 (100)	1 (50)	1 (50)	0	0	2 (100)	1 (50)	0	0	2 (100)	2 (100)
	R	0	0	0	0	1 (50)	1 (50)	2 (100)	2 (100)	0	1 (50)	2 (100)	2 (100)	0	0
E. cloacae (n = 1)	S	1 (100)	0	0	0	0	0	1 (100)	0	1 (100)	1 (100)	0	0	1 (100)	1 (100)
	R	0	1 (100)	0	1 (100)	1 (100)	1 (100)	0	1 (100)	0	0	1 (100)	1 (100)	0	0
K. oxytoca (n = 2)	S	1 (50)	1 (50)	1 (100)	0	1 (50)	1 (50)	0	0	0	0	0	0	1 (50)	1 (50)
	R	1 (50)	1 (50)	0	2 (100)	1 (50)	1 (50)	2 (100)	2 (100)	2 (100)	2 (100)	2 (100)	2 (100)	1 (50)	1 (50)
Total n (%)	S	21 (40.4)	17 (32.7)	3 (5.8)	35 (67.3)	12 (23.1)	7 (13.5)	2 (3.8)	0	33 (63.5)	2 (3.8)	0	1 (2)	22 (42.3)	37 (71.2)
	R	31 (59.6)	35 (67.3)	49 (94.2)	17 (32.7)	40 (76.9)	45 (86.5)	50 (96.2)	52 (100)	19 (36.5)	50 (96.2)	52 (100)	51 (98)	30 (57.7)	15 (28.8)